Vaccinex logo
Vaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb® Application
27 sept. 2023 08h00 HE | Vaccinex, Inc.
Phase 1b/2 pepinemab/PDAC study update to be presented on September 29 at special AACR meeting New ActivMAb® application to be reviewed on September 28 at CHI's 20th Annual Discovery on...